40 results
8-K
EX-10.1
NXEN
Nexien Biopharma, Inc.
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
that:
Investment Purpose. As of the Execution Date, the Buyer is purchasing the Securities for its own account for investment only and not with a view … for this purpose that the Company’s reports filed under the Exchange Act are being incorporated into an effective registration statement filed
8-K
EX-10.2
m9ysb05k ji
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
8-K
EX-10.3
ix0o pfjol4hwpoxl
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
DEF 14C
p0xr5ir3u
8 Mar 19
Information statement
9:35am
8-K
EX-99.1
ser3w9ug1uilkm
26 Feb 19
Nexien BioPharma to File Pre-IND Meeting Request with the FDA
8:55am
8-K
EX-99.1
h6igfme8d4 l6s2
5 Nov 18
Regulation FD Disclosure
5:17pm
8-K
EX-99.1
u4zezoh9uiqjh5hd3lzc
30 Oct 18
Nexien BioPharma Acquires Princeton-Based CRx Bio and Announces Additions to Senior Management
6:18am
8-K
EX-99.1
haf5gqqk3 pb7h2
19 Oct 18
Announces Symbol Change to NXEN
6:15am
8-K
EX-99.1
ymmtxz3rzlg5b hwszs6
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
1:14pm